Mission statement

·   Leading the innovation for the diagnosis and management of liver diseases, cardiovascular diseases and cancer.

    Reducing the burden of liver diseases, cardiovascular diseases and cancers.

Who we are

Hangzhou Proprium Biotech Company Limited (www.propriumbio.com) is located in the Hangzhou Xiasha Economic & Technological Development Area (HEDA), Hangzhou, Zhejiang Province, China. The company was established in 2010 with an initial capital of $10 million (62 million RMB). Propriumbio has a 3000-m² production facility that is certificated by the ISO 13485 International standard, and approved by the Chinese FDA for production of medical devices.

Propriumbio is a market leader in diagnosis and management of liver diseases with several issued patents and pending applications in China, Japan and other countries.

What we do

• ·  Produce diagnostic tests and associated diagnostic equipment for liver diseases, cardiovascular diseases and cancers (Chinese FDA approved).
• ·   Produce products with CE Mark certificates for CE marking countries.
• ·   Offer contract-manufacturing (CMO) services at its GMP facility for clinical diagnostic tests for national and international customers.
• ·   Act as distributors for international diagnostic and reagents companies for sales in China.